{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:25:42Z","timestamp":1793787942852,"version":"4.6.1"},"reference-count":41,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Risk &amp; Safety in Medicine"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>Pharmaceutical quality and safety are critical to public health, yet low- and middle-income countries such as Nigeria remain vulnerable to medicine safety challenges due to weak regulatory enforcement and limited market surveillance. A major concern is contamination of pharmaceutical products with toxic heavy metals, including lead, cadmium, mercury, arsenic, nickel, and chromium. These metals can bioaccumulate and cause adverse health effects even at low concentrations, such as neurodevelopmental impairment, renal and hepatic dysfunction, reproductive toxicity, and cardiovascular complications. This narrative review synthesised evidence on the prevalence of heavy metal contamination in pharmaceuticals marketed in Nigeria, associated health risks, and the adequacy of existing regulatory frameworks.<\/jats:p>\n                  <jats:p>Relevant literature published between 2005 and 2025 was identified through a comprehensive literature search of major databases such as PubMed, Google Scholar, African Journals Online, and Scopus, supplemented with reports from the National Agency for Food and Drug Administration and Control, the World Health Organisation, and grey literature. Studies assessing industrially manufactured or over-the-counter medicines for heavy metal contamination in Nigeria were included.<\/jats:p>\n                  <jats:p>The findings reveal recurrent contamination across several pharmaceutical categories, particularly syrups, locally manufactured analgesics, and herbal preparations. Lead and cadmium were the most frequently reported contaminants, with some products containing multiple metals and exceeding pharmacopeial limits. Heavy metal exposure induces oxidative stress and cellular damage, contributing to kidney injury, neurotoxicity, haematological effects, and endocrine disruption. Children, pregnant women, individuals with renal impairment, and frequent users of herbal medicines were identified as particularly vulnerable. Overall, heavy metal contamination remains a significant medicine safety concern in Nigeria, highlighting the need for stronger regulation, improved analytical capacity, and risk-based surveillance.<\/jats:p>","DOI":"10.1177\/09246479261471793","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:06:51Z","timestamp":1784956011000},"page":"511-518","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Heavy metal contamination in pharmaceuticals: A narrative review of prevalence, health risks, and regulatory gaps in Nigeria"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0844-2976","authenticated-orcid":false,"given":"Blessing Abraham","family":"Ogungbe","sequence":"first","affiliation":[{"name":"Obafemi Awolowo University"},{"name":"Department of Pharmacy, University College Hospital"},{"name":"Young Researchers Hub"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2337-9759","authenticated-orcid":false,"given":"David Ololade","family":"Atanda","sequence":"additional","affiliation":[{"name":"Obafemi Awolowo University"},{"name":"Young Researchers Hub"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet Adedoyin","family":"Bepo","sequence":"additional","affiliation":[{"name":"Obafemi Awolowo University"},{"name":"Young Researchers Hub"},{"name":"Department of Pharmacy, Health Service Commission"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adedamola Akin","family":"Akinyemi","sequence":"additional","affiliation":[{"name":"Obafemi Awolowo University"},{"name":"Young Researchers Hub"},{"name":"Department of Pharmacy, Ekiti State University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.5696\/2156-9614-11.31.210915"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-022-22174-x"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-021-02879-9"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2020.08.009"},{"issue":"1","key":"e_1_3_3_6_2","first-page":"45","article-title":"Investigation of selected metallic impurities in antimalarial herbal decoctions \u201cAgbo Iba\u201d collected from four locations in Lagos State, Nigeria","volume":"6","author":"Alaribe CS","year":"2019","unstructured":"Alaribe CS, Oladipupo AR, Musah AA, et al. Investigation of selected metallic impurities in antimalarial herbal decoctions \u201cAgbo Iba\u201d collected from four locations in Lagos State, Nigeria. UNILAG J Med Sci Technol 2019; 6(1): 45\u201356.","journal-title":"UNILAG J Med Sci Technol"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.595335"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.11648\/j.pst.20190301.13"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1472495"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2025.102073"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.envadv.2025.100620"},{"issue":"2","key":"e_1_3_3_12_2","first-page":"10","article-title":"Heavy metal contamination of pharmaceutical products commonly sold in Nigeria","volume":"2","author":"Onyeloni SO","year":"2022","unstructured":"Onyeloni SO. Heavy metal contamination of pharmaceutical products commonly sold in Nigeria. MUJMHS 2022; 2(2): 10\u201311, Available from: https:\/\/madonnauniversity.edu.ng\/journals\/index.php\/medicine\/article\/view\/60","journal-title":"MUJMHS"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.30574\/gscarr.2024.18.3.0093"},{"issue":"4","key":"e_1_3_3_14_2","first-page":"251","article-title":"Extent of some heavy metals in cough syrups abused in Sokoto, Nigeria","volume":"67","author":"Umar Imam A","year":"2023","unstructured":"Umar Imam A, Sarkingobir Y, Adamu HW, et al. Extent of some heavy metals in cough syrups abused in Sokoto, Nigeria. Chulalongkorn Med J 2023; 67(4): 251\u2013256. https:\/\/doi.org\/10.56808\/2673-060x.5088","journal-title":"Chulalongkorn Med J"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2009.08.033"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e318281db61"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2020.023"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6389"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109050"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-018-1380-4"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1515\/intox-2015-0009"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-024-03903-2"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0006782021"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5439079"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255567"},{"key":"e_1_3_3_26_2","volume-title":"NAFDAC good manufacturing practice (GMP) for pharmaceutical products guidelines 2024","author":"National Agency for Food and Drug Administration and Control (NAFDAC)","year":"2024","unstructured":"National Agency for Food and Drug Administration and Control (NAFDAC). NAFDAC good manufacturing practice (GMP) for pharmaceutical products guidelines 2024. (Doc. Ref. No. DER-GDL-019-03), 2024. Available from: https:\/\/nafdac.gov.ng\/wp-content\/uploads\/Files\/Resources\/Guidelines\/DRUG_GUIDELINES\/NAFDAC-GMP-GUIDELINES.pdf"},{"issue":"2","key":"e_1_3_3_27_2","first-page":"32","article-title":"Drug quality monitoring in Nigeria: progress, challenges and the way forward","volume":"20","author":"Mokuolu OA","year":"2019","unstructured":"Mokuolu OA, Ogunledun A. Drug quality monitoring in Nigeria: progress, challenges and the way forward. Niger J Pharm Sci 2019; 20(2): 32\u201343.","journal-title":"Niger J Pharm Sci"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.51594\/imsrj.v4i3.920"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.104435"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03359"},{"issue":"3","key":"e_1_3_3_31_2","first-page":"406","article-title":"The recent challenge for the pharmaceutical industries \u2013 ICH Q3D Elemental Impurities","volume":"6","author":"Das P","year":"2018","unstructured":"Das P, Kumar SVR, Maity A. The recent challenge for the pharmaceutical industries \u2013 ICH Q3D Elemental Impurities. International Journal of Pharmaceutics and Drug Analysis 2018; 6(3): 406\u2013418.","journal-title":"International Journal of Pharmaceutics and Drug Analysis"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2016.02.001"},{"key":"e_1_3_3_33_2","volume-title":"International council for harmonisation of technical requirements for pharmaceuticals for human use. ICH guideline Q3D(R2): elemental impurities","author":"ICH","year":"2022","unstructured":"ICH. International council for harmonisation of technical requirements for pharmaceuticals for human use. ICH guideline Q3D(R2): elemental impurities, 2022."},{"issue":"10","key":"e_1_3_3_34_2","first-page":"1","article-title":"Heavy metals in pharmaceutical preparations sold in Nigeria: implications for public health","volume":"6","author":"Izah SC","year":"2016","unstructured":"Izah SC, Orinya OK. Heavy metals in pharmaceutical preparations sold in Nigeria: implications for public health. J Health Pollut 2016; 6(10): 1\u20139.","journal-title":"J Health Pollut"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.52225\/narrax.v3i2.226"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211567"},{"key":"e_1_3_3_37_2","unstructured":"National Agency for Food and Drug Administration and Control (NAFDAC). Report of risk-based post-market surveillance of selected medical products in Nigeria carried out in 2021\u20132023. Available from: https:\/\/www.nafdac.gov.ng\/wp-content\/uploads\/Files\/Resources\/Reports\/PMS_Reports\/Report-Of-Risk-Based-Post-Market-Surveillance-Of-Selected-Medical-Products-In-Nigeria-Carried-Out-In-2021-2022-2023.pdf (2023)."},{"issue":"1","key":"e_1_3_3_38_2","first-page":"39","article-title":"The evaluation of potential toxic metal levels of various drugs used in children","volume":"7","author":"\u015eahin S","year":"2024","unstructured":"\u015eahin S, T\u00fcrksoy VA. The evaluation of potential toxic metal levels of various drugs used in children. J Health Sci Med 2024; 7(1): 39\u201346. https:\/\/doi.org\/10.32322\/jhsm.1356020","journal-title":"J Health Sci Med"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25384"},{"key":"e_1_3_3_40_2","volume-title":"Quality control of selected cosmetics marketed in Libya for traces of toxic heavy metals: urgent need for guidelines harmonisation","author":"Rbeida OA","year":"2023","unstructured":"Rbeida OA. Quality control of selected cosmetics marketed in Libya for traces of toxic heavy metals: urgent need for guidelines harmonisation, 2023. https:\/\/doi.org\/10.5281\/ZENODO.8136836"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-91817-6.00009-7"},{"issue":"9","key":"e_1_3_3_42_2","first-page":"14","article-title":"Review of the quality of herbal medicines marketed in Nigeria: regulatory challenges and microbiological safety issues","volume":"12","author":"Esenwah C","year":"2025","unstructured":"Esenwah C, Ubiaru E, Onianwah I, et al. Review of the quality of herbal medicines marketed in Nigeria: regulatory challenges and microbiological safety issues. Int J Innov Res Adv Stud 2025; 12(9): 14\u201320.","journal-title":"Int J Innov Res Adv Stud"}],"container-title":["International Journal of Risk &amp; Safety in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09246479261471793","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09246479261471793","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09246479261471793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:37:50Z","timestamp":1793785070000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09246479261471793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/09246479261471793"],"URL":"https:\/\/doi.org\/10.1177\/09246479261471793","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/09246479261471793\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261471793\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261471793\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261471793\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261471793\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261471793\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261471793\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261471793\/v3\/decision1","asserted-by":"object"}]},"ISSN":["0924-6479","1878-6847"],"issn-type":[{"value":"0924-6479","type":"print"},{"value":"1878-6847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}